Cargando…

A220 ONTARIO POPULATION TRENDS IN INTESTINAL AND EXTRA-INTESTINAL CANCERS OVER 25 YEARS AMONG PERSONS WITH INFLAMMATORY BOWEL DISEASES AND MATCHED CONTROLS

NOT PUBLISHED AT AUTHOR’S REQUEST PLEASE ACKNOWLEDGE ALL FUNDING AGENCIES BY CHECKING THE APPLICABLE BOXES BELOW: CCC, CIHR DISCLOSURE OF INTEREST: S. Murthy: None Declared, G. Kaplan Grant / Research support from: Ferring, Janssen, AbbVie, GlaxoSmith Kline, Merck, and Shire, Consultant of: AbbVie,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Murthy, S K, Kaplan, G G, Coward, S, Kuenzig, E, Benchimol, E I, Zubieta, A, Otley, A, Bitton, A, Bernstein, C N, Targownik, L, Jones, J, Begum, J, Pugliese, M, Singh, H
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Poster Presentations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9991309/ http://dx.doi.org/10.1093/jcag/gwac036.220

Ejemplares similares

A169 THE DIRECT COSTS OF INFLAMMATORY BOWEL DISEASE IN CANADA: A POPULATION-BASED ANALYSIS OF HISTORICAL AND CURRENT COSTS
por: Coward, S, et al.
Publicado: (2023)

A210 THE BURDEN OF IBD HOSPITALIZATION IN CANADA: AN ASSESSMENT OF THE CURRENT AND FUTURE BURDEN IN A NATION-WIDE ANALYSIS
por: Coward, S, et al.
Publicado: (2023)

A35 FORECASTING THE INCIDENCE AND PREVALENCE OF INFLAMMATORY BOWEL DISEASE: A CANADIAN NATION-WIDE ANALYSIS
por: Coward, S, et al.
Publicado: (2023)

The Impact of Inflammatory Bowel Disease in Canada 2018: Extra-intestinal Diseases in IBD
por: Bernstein, Charles N, et al.
Publicado: (2019)

A154 CANCERS ASSOCIATED WITH INFLAMMATORY BOWEL DISEASE IN CANADA: A POPULATION-BASED ANALYSIS OF CASES AND MATCHED CONTROLS
por: Coward, S, et al.
Publicado: (2023)

A189 EMERGENCY DEPARTMENT UTILIZATION AND RISK OF INTESTINAL RESECTION IS LOWER AMONG CHILDREN DIAGNOSED WITH INFLAMMATORY BOWEL DISEASE BEFORE 10 YEARS OF AGE: A MULTIPROVINCE POPULATION-BASED COHORT STUDY
por: Kuenzig, E, et al.
Publicado: (2023)

The Impact of Inflammatory Bowel Disease in Canada 2018: A Scientific Report from the Canadian Gastro-Intestinal Epidemiology Consortium to Crohn’s and Colitis Canada
por: Benchimol, Eric I, et al.
Publicado: (2019)

Hospitalization Rates for Inflammatory Bowel Disease Are Decreasing Over Time: A Population-based Cohort Study
por: Buie, Michael J, et al.
Publicado: (2023)

Introduction of anti-TNF therapy has not yielded expected declines in hospitalisation and intestinal resection rates in inflammatory bowel diseases: a population-based interrupted time series study
por: Murthy, Sanjay K, et al.
Publicado: (2020)

Crohn’s and Colitis Canada’s 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Epidemiology—The Trends of Disease Over Time
por: Coward, Stephanie, et al.
Publicado: (2021)

A183 VARIATION IN HEALTH SERVICES UTILIZATION AND RISK OF SURGERY ACROSS CHILDREN WITH INFLAMMATORY BOWEL DISEASE: A MULTIPROVINCE COHORT STUDY
por: Kuenzig, E, et al.
Publicado: (2023)

The Impact of Inflammatory Bowel Disease in Canada 2018: Direct Costs and Health Services Utilization
por: Kuenzig, M Ellen, et al.
Publicado: (2019)

A168 COSTS OF MISSED WORK AMONG PEOPLE WITH INFLAMMATORY BOWEL DISEASE: A CROSS-SECTIONAL POPULATION-REPRESENTATIVE STUDY
por: Kuenzig, E, et al.
Publicado: (2023)

Variation in care of patients with elderly-onset inflammatory bowel disease in Ontario, Canada: A population-based cohort study
por: Kuenzig, M Ellen, et al.
Publicado: (2020)

A162 CHRONIC OPIOID THERAPY IS ASSOCIATED WITH INCREASED HEALTH SERVICES UTILIZATION AND DIRECT HEALTHCARE COSTS: A POPULATION-BASED STUDY
por: Kuenzig, E, et al.
Publicado: (2022)

A159 OPIOID USE IS DECLINING AMONG PEOPLE WITH INFLAMMATORY BOWEL DISEASE: A POPULATION-BASED STUDY
por: Kuenzig, E, et al.
Publicado: (2022)

Costs of missed work among employed people with inflammatory bowel disease: a cross-sectional population-representative study.
por: Kuenzig, Ellen, et al.
Publicado: (2022)

Uptake of third doses of SARS-CoV-2 vaccines among people with inflammatory bowel disease in Ontario, Canada
por: Kuenzig, M Ellen, et al.
Publicado: (2022)

Inflammatory Bowel Disease Increases the Risk of Venous Thromboembolism in Children: A Population-Based Matched Cohort Study
por: Kuenzig, M Ellen, et al.
Publicado: (2021)

The Impact of Inflammatory Bowel Disease in Canada 2018: Children and Adolescents with IBD
por: Carroll, Matthew W, et al.
Publicado: (2019)

Crohn’s and Colitis Canada’s 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Health Care Delivery During the Pandemic and the Future Model of Inflammatory Bowel Disease Care
por: Jones, Jennifer L, et al.
Publicado: (2021)

Shifting Health Care Use from Hospitalisations and Surgeries to Outpatient Visits in Children with Inflammatory Bowel Disease: A Population-based Cohort Study from Ontario, Canada
por: Dheri, Aman K, et al.
Publicado: (2021)

The Impact of Inflammatory Bowel Disease in Canada 2018: IBD in Seniors
por: Nguyen, Geoffrey C, et al.
Publicado: (2019)

Crohn’s and Colitis Canada’s 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Risk Factors and Medications
por: Targownik, Laura E, et al.
Publicado: (2021)

Crohn’s and Colitis Canada’s 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Seniors With IBD
por: Bernstein, Charles N, et al.
Publicado: (2021)

A177 RISK OF VENOUS THROMBOEMBOLISM IN COVID-19 PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A POPULATION-BASED MATCHED COHORT STUDY
por: Khan, R, et al.
Publicado: (2023)

Crohn’s and Colitis Canada’s 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Mental Health and Quality of Life
por: Graff, Lesley A, et al.
Publicado: (2021)

A182 PREDICTING HIGH DIRECT HEALTHCARE COSTS IN PEDIATRIC PATIENTS WITH INFLAMMATORY BOWEL DISEASE IN THE FIRST YEAR FOLLOWING DIAGNOSIS
por: Kuenzig, E, et al.
Publicado: (2023)

The Impact of Inflammatory Bowel Disease in Canada 2018: Epidemiology
por: Kaplan, Gilaad G, et al.
Publicado: (2019)

The Impact of Inflammatory Bowel Disease in Canada 2018: Quality of Life
por: Jones, Jennifer L, et al.
Publicado: (2019)

Hospitalization With Clostridioides difficile in Pediatric Inflammatory Bowel Disease: a Population-Based Study
por: Kuenzig, M. Ellen, et al.
Publicado: (2022)

Budesonide for the Induction and Maintenance of Remission in Crohn’s Disease: Systematic Review and Meta-Analysis for the Cochrane Collaboration
por: Kuenzig, M Ellen, et al.
Publicado: (2018)

Extra-Peritoneal Wound of Intestines
por: More, P. St. C.
Publicado: (1907)

Crohn’s and Colitis Canada’s 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: COVID-19 Vaccines—Biology, Current Evidence and Recommendations
por: Murthy, Sanjay K, et al.
Publicado: (2021)

Crohn’s and Colitis Canada’s 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Children and Expectant Mothers With Inflammatory Bowel Disease
por: Benchimol, Eric I, et al.
Publicado: (2021)

The 2023 Impact of Inflammatory Bowel Disease in Canada: Executive Summary
por: Windsor, Joseph W, et al.
Publicado: (2023)

The Impact of Inflammatory Bowel Disease in Canada 2018: Indirect Costs of IBD Care
por: Kuenzig, M Ellen, et al.
Publicado: (2019)

Accurate laboratory diagnosis of human intestinal and extra-intestinal amoebiasis
por: Hooshyar, Hossein, et al.
Publicado: (2022)

The Influence of Small Intestinal Bacterial Overgrowth in Digestive and Extra-Intestinal Disorders
por: Losurdo, Giuseppe, et al.
Publicado: (2020)

Crohn’s and Colitis Canada’s 2021 Impact of COVID-19 & Inflammatory Bowel Disease in Canada: A Knowledge Translation Strategy
por: Kaplan, Gilaad G, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_t9pdk2tto9dr7j8h599rqhjnnr